CAS: 6386-24-9; (3R,4S,5S,6R)-3,4,5-Tris(Benzyloxy)-6-((Benzyloxy)Methyl)Tetrahydro-2H-Pyran-2-Ol

结构式图片

欧盟法规

REACH注册C&L通报

上下游产品

Methyl 2,3,4-Tri-O-Benzyl-β-D-Galactopyranoside 40653-32-5
甲基-2,3,4,6-四-O-苄基-Alpha-D-吡喃半乳糖苷 Methyl 2,3,4,6-Tetra-O-Benzyl-α-D-Galactopyranoside 53008-63-2
Methyl 2,3,4,6-Tetra-O-Benzyl α-D-Galactopyranoside 3879-79-6
2,3,4,6-四-O-苄基-D-半乳糖吡喃糖苷甲酯 Methyl 2,3,4,6-Tetra-O-Benzyl-D-Galactopyranoside 195827-82-8
Allyl 2,3,4,6-Tetra-O-Benzyl-D-Galactopyranoside 214490-83-2
Allyl 2,3,4,6-Tetra-O-Benzyl-β-D-Galactopyranoside 60478-61-7
2-Propenyl 2,3,4,6-Tetra-O-Benzyl-α-D-Glactopyranoside 112344-80-6
2-Oxopropyl 2,3,4,6-Tetra-O-Benzyl-α-D-Galactopyranoside 403738-04-5
1-O-乙酰基-2,3,4,6-四-O-苄基-Beta-D-吡喃半乳糖 1-O-Acetyl-2,3,4,6-Tetra-O-Benzyl-β-D-Galactopyranoside 3866-62-4
甲基2,3,4-三-O-苯甲酰-α-D-吡喃葡萄糖苷 Methyl 2,3,4-Tri-O-Benzoylglucopyranoside 34234-44-1

合成工艺路线路线简述

  • 合成目标产物 2,3,4,6-Tetra-O-Benzyl-D-Galactopyranose 主要起始原料 Methyl 2,3,4,6-Tetra-O-Benzyl-A-D-Galactopyranoside
  • (文献来源)合成步骤主要原料 Methyl 2,3,4,6-Tetra-O-Benzyl-A-D-Galactopyranoside
Beta-D-半乳糖五乙酸酯置于三氟甲磺酸,三氟化硼乙醚,Sodium Methylate,三苯基铋,烯丙醇体系中,用 甲醇,二氯甲烷 作为反应溶剂,化学反应 26.5H,反应生成 2,3,4,6-四-O-苄基-D-吡喃半乳糖
参考文献:铋(v)介导的硫糖苷活化
标题:铋(v)介导的硫糖苷活化
摘要:开发了一种简单的利用铋(v)化合物的方法来激活硫丙基丙基糖苷以偶联到各种受体上.在不使用其他添加剂/助促进剂的情况下获得了非常好至极好的收率.该方法不需要低温,适用于多种碳水化合物,并且可以耐受包括烯烃在内的不同官能团.
DOI:10.1002/anie.201304099

海关参考信息

专利信息


专利号:US-2007015793-A1
优先权日:2003-12-23
标 题:Synthesis of nojirimycins
发明人:HIRTH BRADFORD H; RENNIE GLEN
权利人:MACROZYME DNM B V
摘要:Disclosed are methods of preparing substituted nojirimycins represented by the following formula, n n ncomprising reacting 1-deoxynojirimycin with a reagent prepared by reacting an oxidizing agent with the compound represented by the following formula.

专利号:WO-2005063706-A1
优先权日:2003-12-23
标 题 :Synthesis of nojirimycins

专利号:US-7208611-B2
优先权日:2005-02-23
标题 :Platinum-containing compounds exhibiting cytostatic activity, synthesis and methods of use
发明人:GAO QINGZHI; GALLOP MARK A; XIANG JIA-NING
权利人:XENOPORT INC
摘要:Platinum containing compounds exhibiting cytostatic activity, methods of synthesizing platinum-containing compounds exhibiting cytostatic activity pharmaceutical compositions comprising platinum containing compounds, and methods of using such compounds and compositions for treating cancer are disclosed.

专利号:US-2006205677-A1
优先权日:2005-02-23
标题:Platinum-containing compounds exhibiting cytostatic activity, synthesis and methods of use

专利号:WO-2006091790-A1
优先权日:2005-02-23
标题:Platinum-containing compounds exhibiting cytostatic activity, synthesis and methods of use

专利号:CN-102659894-B
优先权日:2012-04-06
标题:A kind of six-carbon sugar ester and its synthesis method and application
华诺化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.varnorchem.com
电话: 0796-8330061 18779971813👤
📞华诺化工有限公司 ⚠️参考联系方式

销售电话:0796-8330061 18779971813
邮箱:sales@varnorchem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

参考标题:Synthesis Of 1,2,3-Triazole Linked Galactopyranosides And Evaluation Of Cholera Toxin Inhibition
作者:David J. Leaver,Raymond M. Dawson,Jonathan M. White,Anastasios Polyzos,Andrew B. Hughes
摘要:We Report The Synthesis Of A Series Of Bivalent 1,2,3-Triazole Linked Galactopyranosides As Potential Inhibitors Of Cholera Toxin (Ct). The Inhibitory Activity Of The Bivalent Series Was Examined (Elisa) And The Series Showed Low Inhibitory Activity (Millimolar Ic50S). Conversely, The Monomeric Galactotriazole Analogues Were Strong Inhibitors Of Cholera Toxin (Ic50 = 71-75 μm).

合成参考文献


摘要:Amii, H., Science of Synthesis: Modern Strategies in Organofluorine Chemistry, (2025) 2.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知